Julia Fraser

Julia Fraser

UN Climate Change Report Assesses Options For Technology And IP Policy

The latest United Nations report on climate change offers advice for international and national intellectual property policies relating to climate change mitigation technology. Although strong IP rights may foster green technology development and transfer in developed countries, there is a lack of evidence to support IP strengthening in developing countries, it concludes.

Special Report: One Year On At The Medicines Patent Pool: Interview With Greg Perry

Greg Perry has been executive director of the Medicines Patent Pool (MPP) for over a year now, since January 2013. Under his guidance, MPP shares that it has launched a “series of new licensing agreements and negotiations with key patent holders and generic medicines companies.” Intellectual Property Watch sat down with Perry recently to discuss why the MPP is so important as an alternative business model, the context of the MPP, changes in the global approach to the issue of access, and how the MPP fits within the Geneva context.

Geneva Health Forum Covers Wide Range Of Policy Issues

Non-communicable diseases, access and affordability, global health governance and information and communications technology innovation are some of the important issues discussed and debated at the recent Geneva Health Forum (GHF).

Geneva Health Forum Meets To Discuss Solutions To Common Problems

The Geneva Health Forum (GHF), taking place on 15-17 April in Geneva, will discuss the theme “Global Health: Interconnected Challenges, Integrated Solutions.” This year’s forum aims to encourage an “integrative approach” to global health, “which better captures the underlying causes of ill-health and recognises the commonalities that underlie people’s health around the world,” says GHF.

WHO Guidelines May Help With Price Reductions For Hepatitis C Drugs

Guidelines for the treatment of hepatitis C released by the World Health Organization today recommend revolutionary new drugs for the virus. However, the exorbitant price of these drugs means they will remain out of reach for most of the millions infected. The WHO guidelines themselves offer limited recommendation for reducing prices, but may help in creating the conditions for price reduction by accruing demand and giving countries official backing in price negotiations.

Book Analyses Chinese IP And Technology Laws

The recently published book “Chinese Intellectual Property and Technology Laws” provides the “first” overview of Chinese IP and technology law, supported by extensive legal, historical and socioeconomic background to developments in these areas.

MPP Drug Licensing Deal Brings Hope For Greater Access To HIV Treatments

The Medicines Patent Pool (MPP) this week announced two new licencing agreements with the private sector joint venture ViiV Healthcare that will increase access to a new antiretroviral in countries hardest hit by HIV.

Assessment Of Climate Change Data Offers Conflicting Advice On IP

A much-discussed new United Nations report on climate change addresses intellectual property issues and the role of innovation in developing technology and disseminate knowledge for local adaption to climate change.